Study of Curcumin, Vorinostat, and Sorafenib

NCT01608139 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: Curcumin
DRUG: Sorafenib
DRUG: Vorinostat

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]